Changes in plasma metallothionein-1, interleukin-6, and C-reactive protein in patients after elective surgery
Akintola, D.F.; Sampson, B.; Burrin, J.; Fleck, A.; Price, C.; Hall, G.
Clinical Chemistry 43(5): 845-847
1997
ISSN/ISBN: 0009-9147 PMID: 9166241 Document Number: 473488
Document emailed within 1 workday
Related Documents
Adler, G.; Eichman, W.; Szczepanski, M.; Targonska, I.; Jasinska, A. 1998: Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction Thrombosis Research 89(5): 243-248Okafor, B.; MacLellan, G. 1998: Postoperative changes of erythrocyte sedimentation rate, plasma viscosity and C-reactive protein levels after hip surgery Acta Orthopaedica Belgica 64(1): 52-56
Elsing, C.; Ernst, S.; Stremmel, W. 2012: Value of Lipopolysaccharide Binding Protein, Interleukin-6 and C-reactive Protein as Biomarkers of Severity in Acute Diverticulitis: A Prospective Study Clinical Laboratory 58(1-2): 145-151
Bremerich, D.H.; Lischke, V.; Asskali, F.; Förster, H.; Behne, M. 2000: Pharmacodynamics and tolerability of acetyl starch as a new plasma volume expander in patients undergoing elective surgery International Journal of Clinical Pharmacology and Therapeutics 38(8): 408-414
Park, Y-Joon.; Oh, E-Jee.; Park, J-Won.; Kim, M.; Han, K. 2006: Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases Annals of Clinical and Laboratory Science 36(3): 262-266
Nazarov, P.G.; Polevshchikov, A.V. 1993: Role of interleukin-2 receptor in mitogenic action of C-reactive protein on lymphocytes Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 9: 13-17
Magalini, S.C.; Nanni, G.; Agnes, S.; Avolio, A.W.; Salvatori, M.; Manna, R.; Castagneto, M. 1991: Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection Transplantation Proceedings 23(4): 2267-2268
He, B.; Ding, S.; Pu, J.; Liu, J-ping.; Song, W.; Du, Y-ping.; Shen, J-yan.; Jin, S-xuan.; Sun, Y.; Shen, L. 2006: Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 34(4): 349-352
Nicolet, C.M.; Burkholder, J.K.; Gan, J.; Culp, J.; Kashmiri, S.V.; Schlom, J.; Yang, N.S.; Sondel, P.M. 1995: Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery Cancer Gene Therapy 2(3): 161-170
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Lin, S.-Y.; Yang, C.-Y.; Lin, H.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease Hepato-Gastroenterology 54(79): 2045-2048
Cekic, C.; Arabul, M.; Alper, E.; Pakoz, Z.B.K.; Saritas, E.; Yuksel; Ünsal, B. 2014: Evaluation of the relationship between serum ghrelin, C-reactive protein and interleukin-6 levels, and disease activity in inflammatory bowel diseases Hepato-Gastroenterology 61(133): 1196-1200
Hirschfield, G. 2001: Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study)--a rebuttal Thrombosis and Haemostasis 85(1): 189-190
Sun, A.; Chu, C.T.; Liu, B.Y.; Wang, J.T.; Leu, J.S.; Chiang, C.P. 2000: Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers Proceedings of the National Science Council Republic of China. Part B Life Sciences 24(3): 116-122
Torrado, H.; Lopez-Delgado, J.C.; Farrero, E.; Rodríguez-Castro, D.; Castro, M.ía.J.; Periche, E.; Carriò, M.L.; Toscano, J.E.; Pinseau, A.; Javierre, C.; Ventura, J.L. 2016: Five-year mortality in cardiac surgery patients with low cardiac output syndrome treated with levosimendan: prognostic evaluation of NT-proBNP and C-reactive protein Minerva Cardioangiologica 64(2): 101-113
Auer, J.W.; Berent, R.; Eber, B. 2001: Lack of association of increased C-reactive protein and total plasma homocysteine Circulation 104(25): E164
Neumaier, M.; Braun, K.F.; Sandmann, G.; Siebenlist, S. 2015: C-Reactive Protein in Orthopaedic Surgery Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 82(5): 327-331
Ng, T. 1997: Erythrocyte sedimentation rate, plasma viscosity and C-reactive protein in clinical practice British Journal of Hospital Medicine 58(10): 521-523
Sattar, N.; McMillan, D.C. 1998: Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer. Measuring C reactive protein concentrations may be more useful Bmj 317(7160): 750-751
Paulus, H.E.; Ramos, B.; Wong, W.K.; Ahmed, A.; Bulpitt, K.; Park, G.; Sterz, M.; Clements, P. 1999: Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists Journal of Rheumatology 26(11): 2324-2331
Qian, J.; Pei, Q.; Jing, R.; Xue, L.; Dong, X.; Ren, G.; Feng, L.; Che, F. 2022: Effects of butylphthalide on the levels of serum C-reactive protein, Parkinson disease protein 7 and neurotrophin-3 and neurological function in patients with acute cerebral infarction Pakistan Journal of Pharmaceutical Sciences 35(1(Special): 349-354